What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Olivier Chosidow spends much of his time researching Dermatology, Internal medicine, Immunology, Surgery and Pathology.
The various areas that he examines in his Dermatology study include Eosinophilia and MEDLINE.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gastroenterology.
His Immunology research is multidisciplinary, relying on both Ivermectin, Epidemiology, Acquired immunodeficiency syndrome, Scabies and Disease.
Olivier Chosidow combines subjects such as Odds ratio, Malathion and Confidence interval with his study of Surgery.
Olivier Chosidow interconnects Cellulitis and Erysipelas in the investigation of issues within Odds ratio.
His most cited work include:
- Risk factors for erysipelas of the leg (cellulitis): case-control study (378 citations)
- Scabies and pediculosis (358 citations)
- Toxic epidermal necrolysis (Lyell syndrome) (326 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Dermatology, Internal medicine, Surgery, Pathology and Immunology.
His Dermatology study incorporates themes from Disease and MEDLINE.
His studies link Gastroenterology with Internal medicine.
His primary area of study in Surgery is in the field of Randomized controlled trial.
A large part of his Pathology studies is devoted to Biopsy.
Olivier Chosidow is interested in Sarcoptes scabiei, which is a field of Scabies.
He most often published in these fields:
- Dermatology (39.69%)
- Internal medicine (20.43%)
- Surgery (17.12%)
What were the highlights of his more recent work (between 2018-2021)?
- Dermatology (39.69%)
- Scabies (12.06%)
- Internal medicine (20.43%)
In recent papers he was focusing on the following fields of study:
Olivier Chosidow mainly focuses on Dermatology, Scabies, Internal medicine, MEDLINE and Toxic epidermal necrolysis.
His research in Dermatology is mostly concerned with Acute generalized exanthematous pustulosis.
The study incorporates disciplines such as Ivermectin, Pediatrics, Outbreak and Public health in addition to Scabies.
His work in Ivermectin covers topics such as Disease which are related to areas like Essential medicines.
His biological study spans a wide range of topics, including Mortality rate, Stevens johnson, Incidence and Retrospective cohort study.
His Retrospective cohort study study integrates concerns from other disciplines, such as Intensive care unit and Soft tissue.
Between 2018 and 2021, his most popular works were:
- The public health control of scabies: priorities for research and action (34 citations)
- The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. (30 citations)
- Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
The scientist’s investigation covers issues in Dermatology, Scabies, Toxic epidermal necrolysis, Stevens johnson and Mortality rate.
He has included themes like Cross-sectional study, Young adult, Down syndrome, Hidradenitis suppurativa and Comorbidity in his Dermatology study.
As part of one scientific family, he deals mainly with the area of Scabies, narrowing it down to issues related to the Public health, and often Epidemiology.
His research in Mortality rate focuses on subjects like Interquartile range, which are connected to Incidence.
In his research on the topic of Ivermectin, Rash is strongly related with Disease.
The MEDLINE study combines topics in areas such as Clinical research, Internal medicine and Delphi method.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
